Gene: TMEM238
Official Full Name: transmembrane protein 238provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13190 | TMEM238 Knockout cell line (HeLa) | Human | TMEM238 | 1:3~1:6 | Negative | Online Inquiry |
KO13191 | TMEM238 Knockout cell line (HCT 116) | Human | TMEM238 | 1:2~1:4 | Negative | Online Inquiry |
KO13192 | TMEM238 Knockout cell line (HEK293) | Human | TMEM238 | 1:3~1:6 | Negative | Online Inquiry |
TMEM238 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically developed to facilitate the study of the TMEM238 gene and its associated biological pathways. These cell lines are created through precise CRISPR-Cas9 technology, which allows for targeted knockout of the TMEM238 gene, enabling researchers to investigate its function and role in diverse physiological and pathological contexts.
The primary mechanism of action relies on the disruption of gene expression, effectively allowing scientists to observe phenotypic changes that occur in cells lacking TMEM238 activity. By comparing these knockout cells with their wild-type counterparts, researchers can explore the gene's involvement in critical processes such as cellular adhesion, differentiation, and potential contributions to disease models, especially in cancer and developmental disorders.
The scientific importance of TMEM238 Gene Knockout Cell Lines lies in their utility for basic research and potential therapeutic applications. In academic and clinical settings, they provide an invaluable resource for elucidating the intricate roles of membrane proteins in health and disease. Understanding TMEM238 functions can lead to the identification of novel biomarkers and targets for drug development, particularly in precision medicine scenarios.
Compared to conventional methods of gene manipulation, our TMEM238 Gene Knockout Cell Lines offer distinct advantages, including higher efficiency and reproducibility, as well as the ability to use a more streamlined approach for scalable experimentation. These lines are rigorously validated for genetic integrity and functionality, ensuring that researchers are working with reliable models that yield accurate and interpretable data.
For researchers and clinicians, investing in TMEM238 Gene Knockout Cell Lines translates to a significant advantage in their investigations, providing tools that not only accelerate findings but also enhance the understanding of genetic contributions to diseases. Our commitment to quality and innovation in biological products, underscored by our expert team with years of experience in genetic engineering, ensures that you receive a product that meets the highest standards in research utility and reliability.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.